Study

EORTC-1944-QLG-STBSG

Long-term survivorship challenges of advanced/metastatic GIST patients responding to Imatinib treatment: An observational study

Study documentation Back to result

Trial Status

Recruiting

Dates

Date of activation: 24-Mar-2021

Data management at EORTC

None

Design

QoL Non Mod Dev.
Not randomized / N.A.

Targeted Sample size

Treatment

None

Study Staff

  • Emma Lidington (Study Coordinator), King's College London - Division of Cancer Studies, London
  • Melanie Beauvois (Clinical Operations Manager), EORTC Headquarters, Brussels
  • Corneel Coens (Statistician), EORTC Headquarters, Brussels
  • Ingrid Desar (Study Co-Coordinator, Study Co-Coordinator), Radboud University Medical Center Nijmegen, Nijmegen
  • Francesca Martinelli (QoL Specialist), EORTC Headquarters, Brussels
  • Madeline Pe (QoL Specialist), EORTC Headquarters, Brussels

Type of cancer

  • Soft Tissue and Bone Sarcoma

Participating groups

  • EORTC Quality of Life Group
  • EORTC Soft Tissue and Bone Sarcoma Group

Protocol summary

http://clinicaltrials.gov/study/

NCT number